Globus Medical (GMED) Q1 Revenue Increases 27% to $759.9 Million

Globus Medical (GMED) reported Q1 revenue of $759.9 million, a 27% increase year over year, and a non-GAAP diluted EPS of $1.12, up 64.7%. The growth was attributed to momentum in U.S. spine, which saw consistent growth for three consecutive quarters at approximately 10%. The company raised its full-year EPS guidance to a range of $4.70 to $4.80. Additionally, Globus reaffirmed revenue guidance of $3.18 billion to $3.22 billion while managing expectations for Nevro revenue integration in the near term.